EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe

O Will Towler iD, Eileen M Shore iD, Frederick S Kaplan

Biomolecules · 2024

DOI: 10.3390/biom14081009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von O Will Towler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic Surgery, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Myositis Ossificans, Ossification, Heterotopic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When a genetic disease is characterized by the abnormal activation of normal molecular pathways and cellular events, it is illuminating to critically examine the places and times of these activities both in health and disease. Therefore, because heterotopic ossification (HO) in fibrodysplasia ossificans progressiva (FOP) is by far the disease’s most prominent symptom, attention is also directed toward the pathways and processes of bone formation during skeletal development. FOP is recognizable by effects of the causative mutation on skeletal development even before HO manifests, specifically in the malformation of the great toes. This signature skeletal phenotype is the most highly penetrant, but is only one among several skeletal abnormalities associated with FOP. Patients may present clinically with joint malformation and ankylosis, particularly in the cervical spine and costovertebral joints, as well as characteristic facial features and a litany of less common, non-skeletal symptoms, all stemming from missense mutations in the ACVR1 gene. In the same way that studying the genetic cause of HO advanced our understanding of HO initiation and progression, insight into the roles of ACVR1 signaling during tissue development, particularly in the musculoskeletal system, can be gained from examining altered skeletal development in individuals with FOP. This review will detail what is known about the molecular mechanisms of developmental phenotypes in FOP and the early role of ACVR1 in skeletal patterning and growth, as well as highlight how better understanding these processes may serve to advance patient care, assessments of patient outcomes, and the fields of bone and joint biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myositis OssificansOssification, HeterotopicHumansAnimalsActivin Receptors, Type IToes

Stichwörter der Autor:innen

ACVR1BMPFOPdigit patterningjoint developmentskeletal development

Substanzen

Activin Receptors, Type IACVR1 protein, human

Autor:innen und Institutionen

  • Division of Plastic Surgery, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Center for Research in FOP and Related Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: O Will Towler, Eileen M Shore

Zitieren

APA

Towler, O. W., Shore, E. M., & Kaplan, F. S. (2024). Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe. Biomolecules. https://doi.org/10.3390/biom14081009

Vancouver

Towler OW, Shore EM, Kaplan FS. Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe. Biomolecules. 2024. doi:10.3390/biom14081009

BibTeX
@article{Towler2024,
  author = {Towler, O Will and Shore, Eileen M and Kaplan, Frederick S},
  title = {Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14081009}
}
Kostenlos starten →